Clearwater Paper (CLW) Q2 2025 Earnings Transcript

Clearwater Paper reported Q2 net sales of $392 million, up 14% year over year, and adjusted EBITDA of $40 million, versus a loss of $8.6 million a year ago, with margins at 10.2%. Management kept full-year revenue guidance at $1.5 billion to $1.6 billion and EBITDA margins longer term at 13%-14%, but guided Q3 adjusted EBITDA down to $10 million to $20 million due to a $23 million to $25 million Lewiston maintenance outage and about 5% lower production volumes. The company also signaled limited room for further buybacks this year because nearly $40 million of planned maintenance spending will constrain free cash flow.

Analysis

CLW is in the awkward middle of the cycle where the equity story is no longer balance-sheet distress, but the next leg up is gated by industry clearing rather than self-help. The second-order issue is that management is effectively telling you FY25 is a trough-earnings year with maintenance and absorption headwinds front-loaded into the next two quarters, so the market should stop capitalizing near-term EBITDA as a run-rate. That makes the stock less about Q2 execution and more about whether 2026 capacity attrition plus trade actions can pull utilization back toward the 90% threshold that converts fixed-cost leverage into equity upside.

The more interesting angle is that CLW’s own strategy may be a hedge against the cycle rather than a pure growth initiative. Converting an existing SBS asset to swing between SBS and CUK adds option value without obvious net capacity growth, which could be attractive if the industry stays oversupplied but product mix remains fragmented. That also means the likely winners are integrated competitors with excess CUK exposure and weaker converter relationships; CLW is trying to buy flexibility while others are still trapped in grade-specific capacity. The downside is that if the conversion decision is approved, the stock may become more of a capital-expenditure story before it becomes a margin story.

The near-term catalyst set is asymmetric but time-lagged: the next 60-90 days are probably about outage execution and whether management avoids another maintenance surprise, while the real rerating catalyst is a clean read on 2026 net capacity reductions or tariff-driven import displacement. The market may be underestimating how quickly fixed-cost leverage can reappear once volumes normalize, but it is also likely overestimating the pace of free cash flow recovery because buybacks are effectively paused by maintenance and capex. In other words, this is not a cash-return story this year; it is a 2026/2027 operating leverage call with a lot of execution risk in the interim.

Key Decisions for Investors

• Maintain a tactical long in CLW only on weakness, sized for a 6-12 month catalyst window; target a rerating if 2026 utilization commentary improves, but cap downside if outage execution or demand softens further.
• Pair trade: long CLW / short a paperboard peer with higher commodity sensitivity and less conversion flexibility; thesis is that CLW’s mix of cost-out + asset optionality should hold up better in a mid-80s utilization regime.
• Avoid chasing the stock into Q3 earnings; the guide implies trough EBITDA and likely headline disappointment versus Q2, so better entry is post-outage when investors can assess whether operations normalized.
• For event-driven desks, consider a small call spread in CLW 6-9 months out to express upside to a 2026 supply-tightening narrative while limiting decay during the maintenance-heavy second half.
• If you need a cleaner expression of the trade-policy catalyst, prefer a basket long CLW against import-exposed packaging names; the upside is contingent on tariffs/duties actually reducing foreign paperboard flow, which is a binary policy risk rather than a steady operating trend.